对多结果生存率的惩罚性降低等级回归数据支持年龄相关疾病的共同代谢风险评分
Marije H Sluiskes1, Hein Putter1, Marian Beekman1
1Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.
Statistics in medicine
|July 15, 2025
概括
一个新的统计模型,惩罚性降低等级回归 (惩罚性survRRR),分析多结果生存数据以了解衰老. 它揭示了基于单个代谢物的得分,预测了英国生物库参与者的与年龄有关的疾病易感性.
科学领域:
- 生物统计学 生物统计学
- 老年学是一门学科.
- 代谢学 代谢学 代谢学
背景情况:
- 老龄化是一个复杂的过程,涉及寿命,健康和疾病发病.
- 多结果健康数据为研究衰老提供了新的途径.
- 现有的模型可能无法完全捕捉到老化数据中的复杂关系.
研究的目的:
- 引入一种新的统计模型,对多结果生存数据进行惩罚性降低等级回归 (惩罚性survRRR).
- 为了确定共同的潜在因素,为多种与年龄相关的结果奠定了基础.
- 为了建模代谢和与年龄有关的疾病之间的复杂相互作用.
主要方法:
- 开发了对多结果生存数据的惩罚性降级回归模型 (惩罚性survRRR).
- 增加了对高维度相关数据的等级约束和处罚.
- 在英国生物库数据 (78,553名参与者) 上应用了激光惩罚的survRRR模型.
主要成果:
- 处罚的survRRRR模型有效地识别了驱动多个结果的共享潜伏因素.
- 一个排名第一的模型证明最适合英国生物库数据.
- 基于单个代谢物对年龄相关疾病易感性的得分得出.
结论:
- 被处罚的survRRR模型为分析复杂的衰老过程提供了一个强大的框架.
- 代谢概况与与年龄相关的疾病易感性密切相关.
- 这种方法为代谢学和衰老研究提供了新的见解.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
292
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
292
Kaplan-Meier Approach
274
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
274
Cancer Survival Analysis
456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456
The Mantel-Cox Log-Rank Test
572
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
572
Assumptions of Survival Analysis
199
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
199
Truncation in Survival Analysis
318
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
318


